Track the 나이벡 share price and the full directors' dealings record of the company, a listed equity based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 나이벡 has logged 26 insider filings. Market capitalisation: €159.3bn. The latest transaction was reported on 16 March 2026 (Other). Among the most active insiders: 정종평. The full history is accessible without an account.
25
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 15,685 of 29,064 companies
49.8
score / 100
Value
37
Quality
63
FCF yld0.3%
Earn yld2.6%
EV/EBITDA21.8x
ROE-0.0%
Gross mgn64%
Net mgn14%
Debt/EBITDA1.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Naivec is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare.